Prescription drug · NDA
Ingrezza (Valbenazine) NDC 70370-2040
Valbenazine tosylate 40 mg/1 · Capsule · Oral · Neurocrine Biosciences, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70370-2040-1 | 70370204001 | 30 CAPSULE in 1 BOTTLE (70370-2040-1)Marketed from Dec 14, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ingrezza
- Generic name (nonproprietary)
- valbenazine
- Active ingredients
- Valbenazine tosylate — 40 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Neurocrine Biosciences, Inc.NDC labeler code 70370
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 209241
- Marketing start
- Listing expires
- Other FDA classes
- Vesicular Monoamine Transporter 2 Inhibitors (Mechanism)
- Identifiers
- Product ID 70370-2040_bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6bSPL ID bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6bSPL set ID 4c970164-cafb-421f-9eb5-c226ef0a3417RxCUI 1918224, 1918230, 1986329, 1986331, 2054268, 2054269, 2541511, 2541513, 2665627, 2665628, 2680779, 2680780, 2680781, 2680782, 2680783, 2680784UNII 5SML1T733BUPC 0370370408011, 0370370404013, 0370370204019, 0370370108010, 0370370406017, 0370370106016
- Pharmacologic class
- Vesicular Monoamine Transporter 2 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470370204001followed by a unit qualifier and the quantityPackage 70370-2040-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INGREZZA and INGREZZA SPRINKLE are indicated for the treatment of adults with: - tardive dyskinesia [see Clinical Studies ( 14.1 )] . - chorea associated with Huntington’s disease [see Clinical Studies ( 14.2 )] . INGREZZA and INGREZZA SPRINKLE are vesicular monoamine transporter 2 (VMAT2) inhibitors indicated for the treatment of adults with: - tardive dyskinesia. ( 1 ) - chorea associated with Huntington’s disease. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 70370-2040
- What is NDC 70370-2040?
- 70370-2040 is the product NDC for Ingrezza (valbenazine), Valbenazine tosylate 40 mg/1 capsule, listed with the FDA by Neurocrine Biosciences, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ingrezza (Valbenazine).
- What is the active ingredient?
- Valbenazine tosylate.
- Who is the labeler?
- Neurocrine Biosciences, Inc., NDC labeler code 70370. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ingrezza?
- 4 other product NDCs are listed under this name. See all Ingrezza NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ingrezza products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ingrezzavalbenazine | — | KitOral | Neurocrine Biosciences, Inc. | 70370-2046 | 70370-2046-01 |
| Ingrezzavalbenazine | Valbenazine tosylate 60 mg/1 | CapsuleOral | Neurocrine Biosciences, Inc. | 70370-1060 | 70370-1060-01 |
| Ingrezzavalbenazine | — | KitOral | Neurocrine Biosciences, Inc. | 70370-2048 | 70370-2048-06 |
| Ingrezzavalbenazine | Valbenazine tosylate 80 mg/1 | CapsuleOral | Neurocrine Biosciences, Inc. | 70370-1080 | 70370-1080-01 |
Other NDCs under NDA 209241
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ingrezzavalbenazine | Valbenazine tosylate 60 mg/1 | CapsuleOral | Neurocrine Biosciences, Inc. | 70370-1060 |
| Ingrezzavalbenazine | Valbenazine tosylate 80 mg/1 | CapsuleOral | Neurocrine Biosciences, Inc. | 70370-1080 |
| Ingrezzavalbenazine | — | KitOral | Neurocrine Biosciences, Inc. | 70370-2046 |
| Ingrezzavalbenazine | — | KitOral | Neurocrine Biosciences, Inc. | 70370-2048 |